Intriguingly, STIM2 protein level—evaluated as a combination of IHC staining intensity and the percentage of positively stained cells—was significantly higher in samples of breast cancer lymph node metastases than in primary breast tumor samples (Fig. 2b). This evidence concerns the gene STIM2 and breast carcinoma.